Abstract
To report long-term outcomes and toxicity rates after chemotherapy (CHT) followed by radiotherapy (RT) in the highly active antiretroviral therapy (HAART) era in human immunodeficiency virus (HIV) positive patients with head and neck diffuse large B cell lymphomas (HN-DLBCL). Clinical data concerning consecutive HIV patients treated for DLBCL located in head and neck region with CHT and RT were retrospectively reviewed. Systemic treatment consisted of combination CHT agents given with concomitant HAART and regimen was left to oncologists’ discretion. Involved field RT was delivered at a total dose of 30–36 Gy (2 Gy per fraction). Survival rates were estimated using the Kaplan–Meier method. Toxicity was evaluated using National Cancer Institute’s Common Terminology Criteria for Adverse Events. Overall, 13 patients were included. There were no missing data. Eight patients had advanced disease (stage III–IV = 8; 61.5%). The most common primary tumor location was oral cavity (n = 7) with large mass at presentation. All patients completed the programmed treatment. Severe acute toxicity was observed in one patient, only. Overall, three patients had died and no treatment-related deaths occurred. After a median follow-up of 152 months, the 20-year overall survival and disease-free survival rates were 65.9 and 41.5%, respectively. Globally, there were no RT-related late complications. This data analysis suggested that CHT followed by RT can be safety proposed in the management of patients with HIV-related HN-DLBCL in the HAART era. Further investigations are necessary to validate our results.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22):1823–1830
Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomark Prev 20(12):2551–2559
Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A (2000) Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 14(12):1675–1688
Cattaneo C, Facchetti F, Re A, Borlenghi E, Majorana A, Bardellini E, Casari S, Tucci A, Conti G, Rossi G (2005) Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma 46(1):77–81
National Comprehensive Cancer Network (2016) Clinical practice guidelines in oncology. Non-Hodgkin’s Lymphomas, version 3. Available at: http://www.nccn.org. Accessed 19 Oct 2016
Cancer Therapy Evaluation Program (2009) Common Terminology Criteria for Adverse Events, Version 4.0. Available from: http://ctep.cancer.gov
International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22):1823–1830
Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, Klein D, Tang B, Silverberg M (2010) Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS 24(11):1765–1770
Lombard M, Michel G, Rives P, Moreau A, Espitalier F, Malard O (2015) Extranodal non-Hodgkin lymphoma of the sinonasal cavities: a 22-case report. Eur Ann Otorhinolaryngol Head Neck Dis 132(5):271–274
Corti M, Villafañe MF, Solari R, De Carolis L, Cangelosi D, Santoro J, Schtirbu R, Lewi D, Bistmans A, Narbaitz M, Baré P (2011) Non-Hodgkin lymphomas of the oral cavity in AIDS patients in a reference hospital of infectious diseases in Argentina: report of eleven cases and review of the literature. J Gastrointest Cancer 42(3):143–148
Corti M, Villafañe M, Bistmans A, Narbaitz M, Gilardi L (2014) Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina. Int Arch Otorhinolaryngol 18(3):260–265
Sirsath NT, Lakshmaiah KC, Das U, Lokanatha D, Chennagiri SP, Ramarao C (2014) Primary extranodal non-Hodgkin’s lymphoma of oral cavity—a single centre retrospective study. J Cancer Res Ther 10(4):945–950
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
De Felice, F., Di Mino, A., Grapulin, L. et al. Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era. Eur Arch Otorhinolaryngol 274, 3735–3739 (2017). https://doi.org/10.1007/s00405-017-4672-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-017-4672-y